Editas Medicine and AskBio Enter Strategic Research Collaboration by bizlift | Oct 15, 2019 | Editas Press Releases, Portfolio News
Editas Medicine and MaxCyte Announce Clinical and Commercial License Agreement by bizlift | Oct 7, 2019 | Editas Press Releases, Portfolio News
Editas Medicine Appoints Cynthia Collins as President and Chief Executive Officer by bizlift | Aug 6, 2019 | Editas Press Releases, Portfolio News
Allergan and Editas Medicine Initiate the Brilliance Phase 1/2 Clinical Trial of AGN-151587 (EDIT-101) for the Treatment of LCA10 by bizlift | Jul 25, 2019 | Editas Press Releases, Portfolio News
Editas Medicine Presents Pre-Clinical Data for Treatment of Sickle Cell Disease and Beta-Thalassemia at the 24th Congress of the European Hematology Association by bizlift | Jun 15, 2019 | Editas Press Releases, Portfolio News
Editas Medicine Announces First Quarter 2019 Results and Update by bizlift | May 7, 2019 | Editas Press Releases, Portfolio News
